International clinical experience with a new low-dose, Monophasic oral contraceptive containing levonorgestrel 100 μg and ethinyl estradiol 20 μg
- 1 January 1999
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 21 (1), 118-127
- https://doi.org/10.1016/s0149-2918(00)88272-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- An open-label, multicenter, noncomparative safety and efficacy study of Mircette™, a low-dose estrogen-progestin oral contraceptiveAmerican Journal of Obstetrics and Gynecology, 1998
- A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cyclesContraception, 1997
- Modern oral contraceptives and cardiovascular diseaseAmerican Journal of Obstetrics and Gynecology, 1997
- A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 μg gestodene, with respect to efficacy, cycle control, and toleranceContraception, 1997
- A new low-dose monophasic combination oral contraceptive (Alesse™) with levonorgestrel 100 μg and ethinyl estradiol 20 μgContraception, 1997
- Inhibition of ovulation by an oral contraceptive containing 100 μg levonorgestrel in combination with 20 μg ethinylestradiolContraception, 1996
- Clinical comparison of two low-dose oral contraceptives, Minulet® and Mercilon®, in women over 30 years of ageContraception, 1994
- Oral contraceptives and cycle control: A critical review of the literatureAdvances in Contraception, 1992
- The Evolution of Oral Contraceptives: Maximizing Efficacy, Minimizing RisksActa Obstetricia et Gynecologica Scandinavica, 1990
- STATISTICAL EVALUATION OF CONTRACEPTIVE METHODSClinical Obstetrics and Gynecology, 1974